Devon Medical Products Wound Therapy Product Lands FDA Approval

The extriCARE2400 Negative Pressure Wound Therapy pump pairs with the company's anatomically fitting bandage products.


Devon Medical Products, a global medical device designer, manufacturer, and distributor, announced it has received Food & Drug Administration (FDA) 510(k) clearance to market its extriCARE 2400 Negative Pressure Wound Therapy (NPWT) system.

The extriCARE 2400 pump weighs only 8.6 ounces and offers patients with specific wounds the ability to live a more active wound-healing lifestyle, the Company said. The pump pairs with Devon Medical Products' easy-to-apply, anatomically fitted bandages that create tight seals around wounds on various areas of the body. Together these technologies promote blood flow and remove exudates into a disposable canister located on the extriCARE 2400 pump.

"We designed and built the extriCARE NPWT system with patients and caregivers in mind after discussions with expert wound care nurses, physicians, and wound management thought leaders," says Dr. John A. Bennett, president of Devon Medical Products. "Ease of application, portability, and bandages creating airtight seals were deemed the most vital features necessary for safe and effective wound closure. The extriCARE encompasses these traits, and we're excited to offer this innovation in negative pressure wound therapy to healthcare professionals and patients."

According to a release, the U.S. patent pending extriCARE 2400 pump is intended for the management of chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, diabetic and pressure ulcers, flaps, and grafts. Using the extriCARE significantly reduces wound preparation time. The extriCARE can be utilized in acute hospital settings, wound clinics, nursing homes, and inside the home under supervision of a trained healthcare professional.

Source: Devon Medical Products

 

No votes yet